295 related articles for article (PubMed ID: 25316153)
1. The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.
Su IJ; Wang LH; Hsieh WC; Wu HC; Teng CF; Tsai HW; Huang W
J Biomed Sci; 2014 Oct; 21(1):98. PubMed ID: 25316153
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
3. Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Teng CF; Wu HC; Shyu WC; Jeng LB; Su IJ
Cell Transplant; 2017 Mar; 26(3):429-438. PubMed ID: 28195035
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis.
Wang HC; Huang W; Lai MD; Su IJ
Cancer Sci; 2006 Aug; 97(8):683-8. PubMed ID: 16863502
[TBL] [Abstract][Full Text] [Related]
5. Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.
Wang LH; Huang W; Lai MD; Su IJ
Carcinogenesis; 2012 Feb; 33(2):466-72. PubMed ID: 22159224
[TBL] [Abstract][Full Text] [Related]
6. Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis.
Wu HC; Tsai HW; Teng CF; Hsieh WC; Lin YJ; Wang LH; Yuan Q; Su IJ
Hum Pathol; 2014 Jun; 45(6):1294-301. PubMed ID: 24767856
[TBL] [Abstract][Full Text] [Related]
7. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
[TBL] [Abstract][Full Text] [Related]
8. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.
Teng CF; Hsieh WC; Wu HC; Lin YJ; Tsai HW; Huang W; Su IJ
PLoS One; 2015; 10(4):e0122373. PubMed ID: 25909713
[TBL] [Abstract][Full Text] [Related]
10. Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
Tsai HW; Lin YJ; Wu HC; Chang TT; Wu IC; Cheng PN; Yen CJ; Chan SH; Huang W; Su IJ
Oncotarget; 2016 May; 7(19):27724-34. PubMed ID: 27027237
[TBL] [Abstract][Full Text] [Related]
11. Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection.
Su IJ; Wang HC; Wu HC; Huang WY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1169-74. PubMed ID: 18505413
[TBL] [Abstract][Full Text] [Related]
12. Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis.
Teng CF; Wu HC; Hsieh WC; Tsai HW; Su IJ
J Virol; 2015 Jan; 89(1):605-14. PubMed ID: 25339766
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
[TBL] [Abstract][Full Text] [Related]
14. Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children.
Abe K; Thung SN; Wu HC; Tran TT; Le Hoang P; Truong KD; Inui A; Jang JJ; Su IJ
Cancer Sci; 2009 Dec; 100(12):2249-54. PubMed ID: 19719772
[TBL] [Abstract][Full Text] [Related]
15. Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy.
Teng CF; Wu HC; Tsai HW; Shiah HS; Huang W; Su IJ
Hepatology; 2011 Oct; 54(4):1199-207. PubMed ID: 21735472
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis.
Yang JC; Teng CF; Wu HC; Tsai HW; Chuang HC; Tsai TF; Hsu YH; Huang W; Wu LW; Su IJ
Hepatology; 2009 Jun; 49(6):1962-71. PubMed ID: 19475690
[TBL] [Abstract][Full Text] [Related]
17. Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma.
Choi YM; Lee SY; Kim BJ
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704071
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I
World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma levels of monocyte chemoattractant protein-1 in patients with hepatitis B virus pre-S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection.
Jeng LB; Li TC; Wang J; Teng CF
Cancer; 2023 Sep; 129(17):2621-2636. PubMed ID: 37096803
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma and hepatitis B surface protein.
Li YW; Yang FC; Lu HQ; Zhang JS
World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
